These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 35475351)
1. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. Chang KY; Duval S; Badesch DB; Bull TM; Chakinala MM; De Marco T; Frantz RP; Hemnes A; Mathai SC; Rosenzweig EB; Ryan JJ; Thenappan T; J Am Heart Assoc; 2022 May; 11(9):e024969. PubMed ID: 35475351 [TBL] [Abstract][Full Text] [Related]
2. Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR). DesJardin JT; Kime N; Kolaitis NA; Kronmal RA; Lammi MR; Mathai SC; Ventetuolo CE; De Marco T; J Heart Lung Transplant; 2024 Jun; 43(6):901-910. PubMed ID: 38360160 [TBL] [Abstract][Full Text] [Related]
3. Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry. Bernardo RJ; Lu D; Ramirez RL; Hedlin H; Kawut SM; Bull T; De Marco T; Ford HJ; Grinnan D; Klinger JR; McConnell JW; Berman-Rosenzweig E; Shlobin OA; Zamanian RT; de Jesus Perez VA Ann Am Thorac Soc; 2022 Sep; 19(9):1459-1468. PubMed ID: 35239467 [No Abstract] [Full Text] [Related]
4. Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR). Garry JD; Kolaitis NA; Kronmal R; Thenappan T; Hemnes A; Grinnan D; Bull T; Chakinala MM; Horn E; Simon MA; De Marco T; J Heart Lung Transplant; 2022 Dec; 41(12):1808-1818. PubMed ID: 36150996 [TBL] [Abstract][Full Text] [Related]
5. Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry. Fling C; De Marco T; Kime NA; Lammi MR; Oppegard LJ; Ryan JJ; Ventetuolo CE; White RJ; Zamanian RT; Leary PJ Ann Am Thorac Soc; 2023 Dec; 20(12):1718-1725. PubMed ID: 37683277 [No Abstract] [Full Text] [Related]
6. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry. Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418 [TBL] [Abstract][Full Text] [Related]
8. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Chung L; Domsic RT; Lingala B; Alkassab F; Bolster M; Csuka ME; Derk C; Fischer A; Frech T; Furst DE; Gomberg-Maitland M; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TA; Molitor JA; Preston IR; Schiopu E; Shapiro L; Silver R; Simms R; Varga J; Gordon JK; Steen VD Arthritis Care Res (Hoboken); 2014 Mar; 66(3):489-95. PubMed ID: 23983198 [TBL] [Abstract][Full Text] [Related]
9. Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand. Strange G; Lau EM; Giannoulatou E; Corrigan C; Kotlyar E; Kermeen F; Williams T; Celermajer DS; Dwyer N; Whitford H; Wrobel JP; Feenstra J; Lavender M; Whyte K; Collins N; Steele P; Proudman S; Thakkar V; Keating D; Keogh A; Heart Lung Circ; 2018 Nov; 27(11):1368-1375. PubMed ID: 29029950 [TBL] [Abstract][Full Text] [Related]
10. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease]. Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483 [No Abstract] [Full Text] [Related]
11. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012 [TBL] [Abstract][Full Text] [Related]
12. Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension. El-Kersh K; Zhao C; Elliott G; Farber HW; Gomberg-Maitland M; Selej M; Garcia-Ferrer J; Benza R Chest; 2023 May; 163(5):1232-1244. PubMed ID: 36634897 [TBL] [Abstract][Full Text] [Related]
13. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry. Boucly A; Weatherald J; Savale L; de Groote P; Cottin V; Prévot G; Chaouat A; Picard F; Horeau-Langlard D; Bourdin A; Jutant EM; Beurnier A; Jevnikar M; Jaïs X; Simonneau G; Montani D; Sitbon O; Humbert M Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737227 [TBL] [Abstract][Full Text] [Related]
14. Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial. Fauvel C; Liu Y; Correa-Jaque P; Kanwar MK; Vizza CD; Lin S; Benza RL Chest; 2023 Dec; 164(6):1518-1530. PubMed ID: 37356711 [TBL] [Abstract][Full Text] [Related]
15. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Park DH; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Lange TJ; Rosenkranz S Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34737226 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502 [TBL] [Abstract][Full Text] [Related]
17. Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry. Medrek S; Sahay S; Zhao C; Selej M; Frost A J Heart Lung Transplant; 2020 Apr; 39(4):321-330. PubMed ID: 32067864 [TBL] [Abstract][Full Text] [Related]
18. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study. Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868 [TBL] [Abstract][Full Text] [Related]
19. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry. Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. Jansa P; Jarkovsky J; Al-Hiti H; Popelova J; Ambroz D; Zatocil T; Votavova R; Polacek P; Maresova J; Aschermann M; Brabec P; Dusek L; Linhart A BMC Pulm Med; 2014 Mar; 14():45. PubMed ID: 24629043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]